Pashupati Advani of Global Foray told CNBC-TV18, "Sun Pharmaceutical Industries is still growing and it is still a great company, but it is getting more expensive to go to hospitals, so why not buy into hospital chains. Very few of them are out there, so that is why they are trading at very high PEs, but more and more are going to get listed as the PE funds come to market. Those are going to be the opportunities that we need to take."
On Friday, Sun Pharmaceutical Industries closed at Rs 947.80, up Rs 5.35, or 0.57 percent. It has touched an intraday high of Rs 955.95 and an intraday low of Rs 939.05.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
